Exploring the Impact of ACE Inhibition in Immunity and Disease면역 및 질병에 대한 ACE 억제의 영향 탐색Review Published on 2022-08-042022-09-11 Journal: Journal of the Renin-Angiotensin-Aldosterone Syste [Category] [DOI] 10.1155/2022/9028969 PMC 바로가기 [Article Type] Review
Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammationCOVID-19 관련 급성 호흡 곤란 증후군(ARDS) 및 전신 염증에 대한 새로운 치료 희망으로서의 인간 태반 유래 양막 상피 세포Review Published on 2022-03-252022-09-11 Journal: Stem Cell Research & Therapy [Category] [DOI] 10.1186/s13287-022-02794-3 PMC 바로가기 [Article Type] Review
Evaluating the effects of sodium glucose co-transporter -2 inhibitors from a renin-angiotensin-aldosterone system perspective in patients infected with COVID-19: contextualizing findings from the dapagliflozin in respiratory failure in patients with COVID-19 studyCOVID-19에 감염된 환자의 레닌-안지오텐신-알도스테론 시스템 관점에서 나트륨 포도당 공동 수송체 -2 억제제의 효과 평가: COVID-19 연구 환자의 호흡 부전에 대한 다파글리플로진의 결과 맥락화Review Published on 2022-03-012022-09-11 Journal: Molecular biology reports [Category] [DOI] 10.1007/s11033-022-07183-w PMC 바로가기 [Article Type] Review
The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatmentCOVID-19와 레닌-안지오텐신-알도스테론 시스템의 상호작용 생리: 치료의 핵심 인자Review Published on 2022-02-012022-09-11 Journal: Pharmacology Research & Perspectives [Category] [DOI] 10.1002/prp2.917 PMC 바로가기 [Article Type] Review
Echocardiography and renin-aldosterone interplay as predictors of death in COVID-19Article Published on 2022-02-012023-06-19 Journal: Archives of cardiovascular diseases [Category] [DOI] 10.1016/j.acvd.2021.11.006 PMC 바로가기
Alterations in cortisol and interleukin-6 secretion in patients with COVID-19 suggestive of neuroendocrine-immune adaptationsArticle Published on 2022-02-012023-07-07 Journal: Endocrine [Category] [DOI] 10.1007/s12020-021-02968-8 PMC 바로가기
Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic interventionCOVID-19 질병의 발병기전에서 ACE-2 수용체의 역할 이해: 치료적 개입을 위한 잠재적 접근Review Published on 2021-12-012022-09-11 Journal: Pharmacological Reports [Category] [DOI] 10.1007/s43440-021-00303-6 PMC 바로가기 [Article Type] Review
Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease안지오텐신 II 수용체 차단제 섭취량은 심혈관 동반 질환 및 CovID-19 질환 환자에서 염증 활성화의 마커 감소 및 사망률 감소와 관련이있다.Research Article Published on 2021-10-212022-09-10 Journal: PLoS ONE [Category] [DOI] 10.1371/journal.pone.0258684 PMC 바로가기 [Article Type] Research Article
Angiotensin–Converting Enzyme (ACE) 1 Gene Polymorphism and Phenotypic Expression of COVID-19 Symptoms안지오텐신-전환 효소(ACE) 1 유전자 다형성 및 COVID-19 증상의 표현형 발현Review Published on 2021-10-012022-09-10 Journal: Genes [Category] [DOI] 10.3390/genes12101572 PMC 바로가기 [Article Type] Review
ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot StudyACE 유전자 변이는 고혈압, 이상지질혈증 또는 당뇨병 환자에서 심각한 COVID-19의 위험을 높입니다: 스페인 파일럿 연구Endocrinology Published on 2021-08-192022-09-11 Journal: Frontiers in Endocrinology [Category] [DOI] 10.3389/fendo.2021.688071 PMC 바로가기 [Article Type] Endocrinology